| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Requests for reprints: Jack D. Griffith, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Mason Farm Road, Chapel Hill, NC 27599. Phone: 919-966-2151; Fax: 919-966-3015; E-mail: jdg{at}med.unc.edu.
The maintenance of telomere length is essential for the indefinite proliferation of cancer cells. This is most often achieved by the activation of telomerase; however, a substantial number of cancers lack detectable telomerase activity and are classified as using an alternative lengthening of telomeres (ALT) pathway. We showed recently that ALT cells have a high level of extrachromosomal telomeric circles (t circles) that may be a specific marker of the ALT phenotype. The mechanism underlying t circle production and the requirement of t circles in ALT remain unclear. Understanding the specific requirements of ALT is key to developing diagnostic tools and therapies that target this pathway and is critical for the treatment of cancers in which ALT is prevalent, including cancers of neuroepithelial and mesenchymal origin. In this study, we used short hairpin RNAs directed at either Xrcc3 or Nbs1, two proteins involved in the homologous recombination pathway, to determine the role of these proteins in t circle production and the requirement of t circles in maintaining the ALT pathway. We show that Xrcc3 and Nbs1 are indeed required for the production of t circles in human ALT. However, these cells continue to proliferate in the absence of t circles, suggesting that they are not required for the survival of ALT cells. [Cancer Res 2007;67(4):15139]
This article has been cited by other articles:
![]() |
A. J. Cesare, C. Groff-Vindman, S. A. Compton, M. J. McEachern, and J. D. Griffith Telomere Loops and Homologous Recombination-Dependent Telomeric Circles in a Kluyveromyces lactis Telomere Mutant Strain Mol. Cell. Biol., January 1, 2008; 28(1): 20 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grudic, A. Jul-Larsen, S. J. Haring, M. S. Wold, P. E. Lonning, R. Bjerkvig, and S. O. Boe Replication protein A prevents accumulation of single-stranded telomeric DNA in cells that use alternative lengthening of telomeres Nucleic Acids Res., December 18, 2007; 35(21): 7267 - 7278. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vespa, R. T. Warrington, P. Mokros, J. Siroky, and D. E. Shippen ATM regulates the length of individual telomere tracts in Arabidopsis PNAS, November 13, 2007; 104(46): 18145 - 18150. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-H. Zhong, W.-Q. Jiang, A. J. Cesare, A. A. Neumann, R. Wadhwa, and R. R. Reddel Disruption of Telomere Maintenance by Depletion of the MRE11/RAD50/NBS1 Complex in Cells That Use Alternative Lengthening of Telomeres J. Biol. Chem., October 5, 2007; 282(40): 29314 - 29322. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kelland Targeting the Limitless Replicative Potential of Cancer: The Telomerase/Telomere Pathway Clin. Cancer Res., September 1, 2007; 13(17): 4960 - 4963. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |